Long term safety and efficacy of open-label infliximab for SLE

被引:0
|
作者
Aringer, M. [1 ]
Houssiau, F. [2 ,3 ]
Graninger, W. B. [4 ]
Feier, E. [5 ]
Steiner, G. [5 ]
Smolen, J. S. [5 ]
机构
[1] Med Univ Vienna, Vienna, Austria
[2] Tech Univ Dresden, Univ Clin Ctr Carl Gustav Carus, Dresden, Germany
[3] Univ Catholique Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[4] Med Univ Graz, Graz, Austria
[5] Med Univ Vienna, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:455 / 455
页数:1
相关论文
共 50 条
  • [41] Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program
    Farnier, Michel
    Hovingh, G. Kees
    Langslet, Gisle
    Dufour, Robert
    Baccara-Dinet, Marie T.
    Din-Bell, Chantal
    Manvelian, Garen
    Guyton, John R.
    ATHEROSCLEROSIS, 2018, 278 : 307 - 314
  • [42] Long-term efficacy/safety of adjunctive eslicarbazepine acetate:open-label extension study in adults with focal seizure
    Biraben, A.
    Grinnell, T.
    Pereira, A.
    Ikedo, F.
    Moreira, J.
    Gama, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 480 - 480
  • [43] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Tarantino, M.
    Bussel, J.
    Blanchette, V.
    Despotovic, J.
    Bennett, C.
    Raj, A.
    Williams, B.
    Beam, D.
    Morales, J.
    Rose, M.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 587 - 587
  • [44] Assessment of the long-term efficacy and safety of adjunctive perampanel: pooled analyses of four open-label extension studies
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    NEUROLOGY, 2017, 88
  • [45] LONG-TERM EFFICACY AND SAFETY OF ADJUNCTIVE PERAMPANEL IN OPEN-LABEL EXTENSION (OLEX) STUDIES: A POST HOC ANALYSIS
    Rektor, I.
    Krauss, G. L.
    Inoue, Y.
    Kaneko, S.
    Williams, B.
    Patten, A.
    Bibbiani, F.
    Laurenza, A.
    Wechsler, R. T.
    EPILEPSIA, 2017, 58 : S110 - S110
  • [46] Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
    Klein, Pavel
    Aboumatar, Sami
    Brandt, Christian
    Dong, Fang
    Krauss, Gregory L.
    Mizne, Sarah
    Sanchez-Alvarez, Juan Carlos
    Steinhoff, Bernhard J.
    Villanueva, Vicente
    NEUROLOGY, 2022, 99 (10) : E989 - E998
  • [47] Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson<acute accent>s Disease
    Peball, Marina
    Heim, Beatrice
    Carbone, Federico
    Schorr, Oliver
    Werkmann, Mario
    Ellmerer, Philipp
    Marini, Kathrin
    Krismer, Florian
    Knaus, Hans-Guenther
    Poewe, Werner
    Djamshidian, Atbin
    Seppi, Klaus
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [48] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [49] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
  • [50] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Bussel, James
    Tarantino, Michael
    Blanchette, Victor
    Raj, Ashok
    Despotovic, Jenny
    Beam, Donald
    Roy, John
    Wang, Xuena
    Mehta, Bhakti
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S9 - S9